Literature DB >> 10845878

Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.

A Gnasso1, C Motti, C Irace, C Carallo, L Liberatoscioli, S Bernardini, R Massoud, P L Mattioli, G Federici, C Cortese.   

Abstract

A common variant in the promoter of the human stromelysin gene, causing reduced enzyme expression, has been associated with the progression of coronary atherosclerosis. On the other hand, increased stromelysin activity may promote plaque rupture. The present study was undertaken to investigate the relationship between the genetic variation in the human stromelysin gene promoter and common carotid geometry. Forty-two healthy male subjects without major coronary heart disease risk factors were investigated. The polymorphism in the stromelysin gene promoter was studied through polymerase chain reaction amplification with the use of mutagenic primers. Age, blood pressure, lipids, glucose, viscosity, and body mass index were similar in homozygotes for the 5A allele (5A/5A), heterozygotes (5A/6A), and homozygotes for the 6A allele (6A/6A). Serum matrix metalloproteinase-3 levels did not differ significantly among genotypes. Common carotid diameters and intima-media thickness, measured by noninvasive ultrasonography, were significantly larger in 6A/6A subjects (for respective 6A/6A, 5A/6A, and 5A/5A subjects, diameter at the R wave was 0.63+/-0.09, 0.55+/-0.06, and 0.53+/-0.04 cm [mean+/-SD], P<0.005 by ANOVA; intima-media thickness was 765+/-116, 670+/-116, and 630+/-92 microm [mean+/-SD], P<0.05 by ANOVA). Wall shear stress, calculated as blood velocityxblood viscosity/internal diameter, was significantly lower in 6A/6A subjects (for respective 6A/6A, 5A/6A, and 5A/5A subjects, mean wall shear stress was 10.4+/-2.9, 13.5+/-3.5, and 12.6+/-1.9 dyne/cm(2) [mean+/-SD], P<0.05 by ANOVA). The results demonstrate that the gene polymorphism in the promoter region of stromelysin is associated with structural and functional characteristics of the common carotid artery in healthy male subjects without major risk factors for atherosclerosis. Individuals with the 6A/6A genotype (associated with lower enzyme activity) show a triad of events, namely, increased wall thickness, enlarged arterial lumen, and local reduction of wall shear stress, which might predispose them to atherosclerotic plaque localization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845878     DOI: 10.1161/01.atv.20.6.1600

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

1.  Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.

Authors:  Klaus Kallenbach; Rolf Salcher; Albert Heim; Matthias Karck; Paolo Mignatti; Axel Haverich
Journal:  J Vasc Surg       Date:  2009-03       Impact factor: 4.268

2.  Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.

Authors:  Tamara Djurić; Maja Zivković; Aleksandra Stanković; Sanja Mecanin; Dragan Alavantić
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

4.  Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.

Authors:  Hari Om Singh; Shruti D Marathe; Sumitra Nain; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

Review 5.  Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.

Authors:  Timmy Lee; Davinder Wadehra
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

6.  Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.

Authors:  Chih-Ching Lin; Wu-Chang Yang; Ming-Yi Chung; Pui-Ching Lee
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

7.  Age-dependent loss of MMP-3 in Hutchinson-Gilford progeria syndrome.

Authors:  Ingrid A Harten; Rima S Zahr; Joan M Lemire; Jason T Machan; Marsha A Moses; Robert J Doiron; Adam S Curatolo; Frank G Rothman; Thomas N Wight; Bryan P Toole; Leslie B Gordon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-17       Impact factor: 6.053

8.  Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB.

Authors:  Veronika Souslova; Paul A Townsend; Jelena Mann; Chris M van der Loos; Anna Motterle; Fulvio D'Acquisto; Derek A Mann; Shu Ye
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

9.  Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Authors:  Ajay K Chaudhary; Mamta Singh; Alok C Bharti; Mangal Singh; Shirish Shukla; Atul K Singh; Ravi Mehrotra
Journal:  BMC Cancer       Date:  2010-07-14       Impact factor: 4.430

Review 10.  Genomics, heart failure and sudden cardiac death.

Authors:  Dawood Darbar
Journal:  Heart Fail Rev       Date:  2008-04-24       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.